Mary Cromwell

Dr. Cromwell has more than 30 years’ experience in the biotechnology industry. Prior to joining Allakos, Dr. Cromwell was Vice President for Quality, Drug Substance at Genentech/Roche. She began her career at Genentech in the Pharmaceutical Development group where she developed formulations for several molecules in various stages of development. She has held leadership positions in Protein Analytical Chemistry, Pharmaceutical Development, and Global Biologics Manufacturing Sciences and Technologies & Global Packaging Development prior to her role in Quality. Dr. Cromwell was directly involved in the licensure of numerous Genentech/Roche products, including Avastin® and Perjeta®. She served as a member of the Genentech Foundation Board, a non-profit organization that provided funding to improve the success of students from underrepresented groups in post-secondary STEM education.

Dr. Cromwell received a BS in Chemistry from West Virginia University, an MS in Biophysical Chemistry from the University of California-Berkeley, and a PhD in Pharmaceutical Sciences from the University of Colorado-Denver.